Bioinformatics News Nov 2007: bioinformatics, genomics, proteomics, microarray, etc.

Previous 1 2 3 4 Next

Mitrionics and SGI Customers Validate Global Demand for Accelerated FPGA Technology
Mitrionics(TM), Inc., developer of the Mitrion(TM) Software Acceleration Platform and the Mitrion Virtual Processor, today announced a growing number of global companies, organizations, and universities that are using their accelerated FPGA technology platform and NCBI BLAST-n application. The Mitrion-Accelerated BLAST application runs on a turnkey SGI® RASC(TM) RC100 blade system equipped with ... (Wed, 07 Nov 2007 14:30:00 GMT)

Translational Research Benefits From $6.37 Million To Find New Ways To Treat Psoriasis
The National Institute of Arthritis and Musculoskeletal Skin Diseases (NIAMS), a research center at the National Institutes of Health (NIH), has awarded Case Western Reserve University School of Medicine and University Hospitals Case Medical Center a $6.37 million award to establish a Center of Research Translation (CORT) for the skin disease psoriasis. [click link for full article] (Wed, 07 Nov 2007 15:50:22 GMT)

SeedQuest - Central information website for the global seed industry
Providing food security, one of the greatest challenges of our time, is a critical goal especially in the developing world, where crop destruction by drought, disease and pest infestation swiftly places millions of lives at risk of hunger. (Wed, 07 Nov 2007 16:46:43 GMT)

FibroGen Announces New Research in HIF and CTGF Therapeutic Programs Presented at the Annual Meeting of the American ...
SAN FRANCISCO----FibroGen, Inc. today announced data from research on its therapeutic programs targeting hypoxia-inducible factor prolyl hydroxylase and connective tissue growth factor reported at the 40th annual meeting of the American Society of Nephrology Renal Week November 2 - 5, 2007, in San Francisco, CA. (Wed, 07 Nov 2007 16:59:00 GMT)

Scientists compare 12 fruit fly genomes
An international research consortium of scientists, supported by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced publications comparing the genome sequences of 12 closely related fruit fly species, 10 of which were sequenced for the first time. (Wed, 07 Nov 2007 18:11:49 GMT)

New Reagent From Applied Biosystems Accelerates Real-Time PCR
Applied Biosystems, an Applera Corporation business, today introduced a new master mix reagent designed to accelerate real-time PCR (polymerase chain reaction) (Wed, 07 Nov 2007 18:37:41 GMT)

UC Riverside Lands $1.7M Grant to Use Genomics to Improve Cowpea Cultivars
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 07 Nov 2007 20:27:56 GMT)

New dengue viral host genes identified
Singaporean scientists have identified new host genes linked with the dengue virus, possibly leading to creation of drugs to treat the disease. Researchers at the Novartis Institute for Tropical Diseases and the Genome Institute of Singapore, led by Subha... (Wed, 07 Nov 2007 20:45:48 GMT)

AnaSpec Introduces HiLytePlus(TM) - AnaSpec's Highest Performance Fluorescent Dyes
SAN JOSE, Calif.----This week AnaSpec announced the release of the HiLytePlus™ series of fluorescent dyes. Demonstrating even greater brightness than AnaSpec's HiLyte Fluor™ line, this series represents the next generation in AnaSpec's line of high performance fluorescent dyes. (Wed, 07 Nov 2007 20:54:00 GMT)

Boston University Medical Center researcher's abstract selected by Society for Neuroscience
Boston, MA—David Farb, PhD, recently had an abstract selected that was highlighted by the Society for Neuroscience (SFN). The abstract details how antioxidants influence dopamine release from striatal synaptosomes. (Wed, 07 Nov 2007 21:14:31 GMT)

Evolution and Fly Genomics
New work on fruit fly genomics suggests new ways to look at the much larger human genome, and gives insights into the role of adaptation in evolution. (Wed, 07 Nov 2007 21:45:56 GMT)

Applied Digital Reports 2007 Third Quarter Financial Results
DELRAY BEACH, Fla.----Applied Digital Solutions, Inc. , a leading provider of identification and security technology, today reported financial results for its third quarter ended September 30, 2007. (Wed, 07 Nov 2007 22:02:00 GMT)

News: Emerging field: Bioinformatics: Conference on campus showcases University lead on frontier
Researchers gathered together this week to discuss new ways in which computers can help to diagnose and treat disease as Stanford hosted the fifth annual Computational Systems Bioinformatics Conference, Aug. 14 through tomorrow. (Thu, 08 Nov 2007 01:06:43 GMT)

A Better Recommendation Engine
Cleverset's approach to e-commerce exposes consumers to the long tail. (Thu, 08 Nov 2007 05:01:32 GMT)

A Novel Approach to DNA Analysis
Comparing fruit flies reveals a new way to identify the functional elements of genomes. (Thu, 08 Nov 2007 05:01:42 GMT)

New Life, New Rules
Bioengineer J. Craig Venter is expected to announce within the next few months, perhaps weeks, that he and his company, Synthetic Genomics of Rockvile, Md. and La Jolla, Calif., have created Earth’s first artificial life form. (Thu, 08 Nov 2007 05:41:18 GMT)

Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and Third Quarter 2007 Financial Results
Cell Therapeutics, Inc. today reported recent accomplishments and financial results for the quarter and nine months ended September 30, 2007. (Thu, 08 Nov 2007 06:30:00 GMT)

BASF sees future profits in a genetically modified potato
Approval by the European Commission would help BASF push other commodities through its biotechnology pipeline, including a blight-resistant potato. (Thu, 08 Nov 2007 06:45:59 GMT)

New medical IT administrator named
Joyce Mitchell was appointed to the position of associate vice president for health sciences information technology last month. Mitchell will direct and coordinate clinical and information technology services for the U's health sciences. Mitchell came to the U two years ago as a professor of bioinformatics and became chair of the medical school's department of biomedical informatics. (Thu, 08 Nov 2007 08:57:54 GMT)

Society For Neuroscience Selects Boston University Medical Center Researcher's Abstract
David Farb, PhD, recently had an abstract selected that was highlighted by the Society for Neuroscience (SFN). The abstract details how antioxidants influence dopamine release from striatal synaptosomes. It was presented at SFN's 37th annual meeting November 7th in San Diego, California. [click link for full article] (Thu, 08 Nov 2007 11:19:43 GMT)

Medarex Announces Presentations on UltiMAb(R) Antibodies at 71st Annual Meeting of the American College of Rheumatology
Medarex, Inc. announced today that at least five antibodies generated from Medarex's UltiMAb® technology in which Medarex wholly owns or has an economic interest through co-promote/profit sharing rights, royalties and/or equity ownership, are expected to be the subject of oral or poster presentations at the 71st Annual Meeting of the American College of Rheumatology , being held November 6-11, ... (Thu, 08 Nov 2007 12:00:00 GMT)

Spending bill has nearly $4 million for area
WASHINGTON — The House has approved a spending bill for labor and health programs and military construction that includes a treasure trove of earmarks for Western New York — including projects that prompted Republican Reps. Thomas M. Reynolds and Randy Kuhl to buck the White House and support it. (Thu, 08 Nov 2007 12:16:50 GMT)

Stellar Pharmaceuticals Announces Profitability for 2007 Third Quarter Financial Results
Stellar Pharmaceuticals Inc.(OTC.BB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced financial results for the third quarter ended September 30, 2007. (Thu, 08 Nov 2007 12:30:00 GMT)

Rosetta Genomics Reports Third Quarter 2007 Financial Results
Rosetta Genomics, Ltd. , a global leader in the field of microRNA, reported today its consolidated financial results for the quarter and six months ended October 30, 2007, and business highlights. (Thu, 08 Nov 2007 12:45:00 GMT)

MedImmune Presents Data from Its Advancing Inflammatory Disease Portfolio at 71st Annual Meeting of The American ...
MedImmune, Inc. today announced it will present 11 abstracts at the 71st Annual Meeting of the American College of Rheumatology, demonstrating the company's breadth of ongoing, multi-stage research evaluating the origins and effects of inflammatory disease and novel disease pathways. (Thu, 08 Nov 2007 13:00:00 GMT)

Scientists Compare Twelve Fruit Fly Genomes
Fly Consortium Uncovers Swarm of Novel Findings About Genomic Evolution, Function (Thu, 08 Nov 2007 13:58:04 GMT)

SGI Builds World's Largest FPGA Supercomputer, Boosts Nucleotide Query Performance By More Than 900 Times Over 68-Node ...
SGI today announced it built the world's largest Field Programmable Gate Array supercomputer configuration, then ran a broadly used bioinformatics application more than 900 times faster than the same application would run on a traditional cluster. (Thu, 08 Nov 2007 14:00:00 GMT)

PGI Compilers and Tools from The Portland Group
64-bit high-performance parallel Fortran, C and C++ Tools support Mac OS X Leopard Portland, Ore, October 29, 2007 - The Portland Group®, a wholly-owned subsidiary of STMicroelectronics (NYSE: STM) and leading supplier of compilers for high-performance computing (HPC), today announced the general availability of its PGI® Workstation suite of 64-bit high-performance parallel compilers and tools ... (Thu, 08 Nov 2007 14:36:01 GMT)

Biological Sciences Symposium Showcases Grad Student Work
Durham, NC -- The 16 th Biological Sciences Graduate Student Symposium will showcase a wide variety of biological research conducted by graduate students at Duke University including novel, cutting-edge research in biochemistry, cancer biology, cell biology, genomics, immunology, molecular biology, neurobiology, pharmacology, and toxicology. (Thu, 08 Nov 2007 14:36:31 GMT)

AnaSpec Introduces HiLytePlus™ – AnaSpec’s Highest Performance Fluorescent Dyes AnaSpec Inc. Posted on: 08 Nov 07
This week AnaSpec announced the release of the HiLytePlus™ series of fluorescent dyes. Demonstrating even greater brightness than AnaSpec’s HiLyte Fluor™ line, this series represents the next generation in AnaSpec’s line of high performance fluorescent dyes. (Thu, 08 Nov 2007 15:27:06 GMT)

Rosetta Genomics Posts $2.2M Net Loss for Q3
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Thu, 08 Nov 2007 15:57:16 GMT)

NASA Spaceline 26 October 2007 Current Space Life Science Awareness
Norrbrand L, Fluckey JD, Pozzo M, Tesch PA. Resistance training using eccentric overload induces early adaptations in skeletal muscle size. Eur J Appl Physiol. 2007 Oct 10; [Epub ahead of print] (PI: P.A. Tesch) (Thu, 08 Nov 2007 16:27:38 GMT)

The genetic basis of inbreeding avoidance in house mice
A new study appearing online on November 8th in Current Biology, a publication of Cell Press, offers new insight into how wild house mice avoid mating with their relatives. (Thu, 08 Nov 2007 17:15:23 GMT)

ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood
ExonHit Therapeutics, a drug and diagnostic discovery company, has completed a prototype of the first blood-based Alzheimer's disease test. The company expects to have this test certified and to provide it as a service in its GLP compliant laboratories to the pharmaceutical industry as early as 2009. (Thu, 08 Nov 2007 17:59:00 GMT)

Studies Investigate Diagnostic Performance And Reproducibility Of Pathwork Diagnostics' Tissue Of Origin Test
Pathwork Diagnostics, a genomics-based diagnostics company focused on oncology, announced that its Pathwork Tissue of Origin Test is the focus of two studies featured in poster presentations at this week's 12th Annual Meeting of the Association for Molecular Pathology (November 7-10, Los Angeles) (Thu, 08 Nov 2007 18:22:31 GMT)

Monarch LifeSciences Proteomic Technologies Have identified And quantified Promising Biomarkers In Ovarian Cancer Cells
Ovarian cancer is the leading cause of death among all gynecological cancers. Most patients with the disease are initially responsive to platinum-based chemotherapy treatments, such as cisplatin, but they eventually relapse and become resistant to additional treatment (Thu, 08 Nov 2007 18:22:41 GMT)

BIO Welcomes New Report Detailing Policy Options To Ensure Responsible Use Of Synthetic Biology
The Biotechnology Industry Organization (BIO) applauded the report "Synthetic Genomics: Options for Governance," released by the J. Craig Venter Institute, the Center for Strategic and International Studies, and the Massachusetts Institute of Technology (Thu, 08 Nov 2007 18:22:51 GMT)

Medarex Announces Presentations on UltiMAb(R) Antibodies at 71st Annual Meeting of the American College of Rheumatology
PRINCETON, N.J. ( Map ) - PRINCETON, N.J., Nov. 8 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today that at least five antibodies generated from Medarex's UltiMAb(R) technology in which Medarex wholly owns or has an economic interest through co-promote/profit sharing rights, royalties and/or equity ownership, are expected to be the subject of oral or poster presentations at ... (Thu, 08 Nov 2007 18:40:17 GMT)

MedImmune Presents Data from Its Advancing Inflammatory Disease Portfolio at 71st Annual Meeting of The American ...
BOSTON , Nov. 8 /PRNewswire/ -- MedImmune, Inc. today announced it will present 11 abstracts at the 71st Annual Meeting of the American College of Rheumatology, demonstrating the company's breadth of ongoing, multi-stage research evaluating the origins and effects of inflammatory disease and novel disease pathways. (Thu, 08 Nov 2007 19:09:56 GMT)

ParaMEDIC Enables Worldwide Supercomputer for Bioinformatics
A large-scale sequence-searching problem, like identifying genes, can exceed the computational and storage resources of a supercomputing site. A research team from Argonne National Laboratory and Virginia Tech have created a worldwide supercomputer and developed a novel framework that can accelerate the speed of parallelized bioinformatics programs by 27-fold. (Thu, 08 Nov 2007 21:27:57 GMT)

British Library Selects Apex CoVantage as Digitization Partner in Expanding the Repository of UK PubMed Central
Apex CoVantage, a leading knowledge process outsourcing (KPO) company, is pleased to announce another renewal from one of its long-standing customers, the British Library. (Fri, 09 Nov 2007 07:01:00 GMT)

Human Evolution And Fly Genomics
New work on fruit fly genomics suggests new ways to look at the much larger human genome, and gives insights into the role of adaptation in evolution. [click link for full article] (Fri, 09 Nov 2007 10:20:33 GMT)

Three New Studies Show Benefits Of NuVim's Key Ingredient
NuVim, Inc. (OTCBB:NUVM) announced that three studies were recently published relating to GTC Nutrition's flagship ingredient solution NutraFlora(R) (short-chain fructooligosaccharides (scFOS®) prebiotic fiber). [click link for full article] (Fri, 09 Nov 2007 11:18:42 GMT)

Safeway To Donate Nearly $17 Million For Critical Breast Cancer Research And Prevention Programs
Safeway Inc. (NYSE:SWY) announced it will provide nearly $17 million for critical breast cancer research and prevention programs in the United States and Canada. [click link for full article] (Fri, 09 Nov 2007 19:17:43 GMT)

Landmark trial to evaluate cardioprotective properties of insulin
The ability of insulin to limit heart-tissue damage during a heart attack will be tested in a landmark clinical trial led by Paresh Dandona, M.D., Ph.D., University at Buffalo Distinguished Professor in the departments of Medicine and Pharmacology and Toxicology in the UB School of Medicine and Biomedical Sciences. (Fri, 09 Nov 2007 20:21:19 GMT)

Nanogen to Host Third Quarter Conference Call on November 12, 2007
SAN DIEGO----Nanogen, Inc. , developer of advanced diagnostic products, will host a conference call on Monday, November 12, 2007 at 4:30 p.m. Eastern to discuss 2007 third quarter financial results. (Fri, 09 Nov 2007 21:48:00 GMT)

Nanogen to Host Third Quarter Conference Call on November 12, 2007
Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, will host a conference call on Monday, November 12, 2007 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to discuss 2007 third quarter financial results. The financial ... (Fri, 09 Nov 2007 21:58:53 GMT)

Noticias Infobolsa / Titulares
09/11/2007 21:48:00 Business Wire Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, will host a conference call on Monday, November 12, 2007 at 4:30 p.m. (Fri, 09 Nov 2007 22:02:36 GMT)

Luminex Corporation Announces Finalization of the Purchase Price Allocation Related to Tm Bioscience Acquisition
AUSTIN, Texas----Luminex Corporation today announced that it had completed its allocation of the purchase price related to the acquisition of Tm Bioscience completed on March 1, 2007. (Fri, 09 Nov 2007 22:19:00 GMT)

Noticias Infobolsa / Titulares
Luminex Corporation Announces Finalization of the Purchase Price . Allocation Related to Tm Bioscience Acquisition Allocation Related to Tm Bioscience Acquisition 09/11/2007 22:19:00 Business Wire US9666211043 Luminex Corporation (NASDAQ:LMNX) today announced that it had completed its allocation of the purchase price related to the acquisition of Tm Bioscience completed on March 1, 2007. (Fri, 09 Nov 2007 22:32:22 GMT)

Luminex Corporation Announces Finalization of the Purchase Price Allocation Related to Tm Bioscience Acquisition
Luminex Corporation ( Nachrichten ) (NASDAQ:LMNX) today announced that it had completed its allocation of the purchase price related to the acquisition of Tm Bioscience completed on March 1, 2007. (Fri, 09 Nov 2007 22:32:30 GMT)

Safeway to give nearly $17 million for breast cancer research
Safeway Inc. said Thursday it will provide nearly $17 million for breast cancer research and prevention programs in the United States and Canada, following a month-long fundraising and public service campaign in all of its 1,738 stores. (SWY) (Fri, 09 Nov 2007 23:00:53 GMT)

Trial To Evaluate Cardioprotective Properties Of Insulin
The ability of insulin to limit heart-tissue damage during a heart attack will be tested in a new clinical trial. The trial is based on a pilot study conducted by the diabetes center, which documented that insulin, used to treat and control type 1 and type 2 diabetes, was also cardioprotective. (Fri, 09 Nov 2007 23:02:47 GMT)

Gene Expression Profiling Of Dengue Virus Infection In Cell Lines And Patients
Researchers have identified new host genes associated with dengue virus infection, which may open new avenues to developing a drug to treat the disease. The results suggest that drugs that target the host pathways may prove effective against dengue. (Sat, 10 Nov 2007 01:02:27 GMT)

The Unraveling
J. Craig Venter raced the government to decode a human genome. (Sat, 10 Nov 2007 06:07:25 GMT)

Scientists crack code of drug-resistant TB
Durban, Nov 10 (IANS) South African scientists have sequenced the entire genome of a strain of extremely drug-resistant mycobacterium tuberculosis (XDR-TB). (Sat, 10 Nov 2007 07:21:38 GMT)

The Genetic Basis Of Inbreeding Avoidance
A new study appearing online on November 8th in Current Biology, a publication of Cell Press, offers new insight into how wild house mice avoid mating with their relatives. The mice rely on a diverse set of specially evolved proteins in their urine, called major urinary proteins (MUPs), to identify relatives and avoid mating with them. [click link for full article] (Sat, 10 Nov 2007 17:02:42 GMT)

National Yang Ming University students win science gold
A team students from National Yang Ming University (NYMU) students have won a gold medal at the International Genetic Engineering Machine 2007 (iGEM 2007) competition. (Sat, 10 Nov 2007 21:07:44 GMT)

Functional harmony
There’s vast potential for functional foods in Asia, as a recent conference indicated. (Sat, 10 Nov 2007 23:42:36 GMT)

Next Steps: New blood tests might predict Alzheimer’s
QUESTION: During the past several years, my mother, now 83 years old, started becoming increasingly forgetful — leaving the oven on, locking herself outside her house, losing her car keys, getting lost near her house, and so on. My sisters and I took her to her family doctor, who gave her some cognitive tests. Although he said the results were inconclusive, the doctor told us Mom “might” have ... (Sun, 11 Nov 2007 05:05:04 GMT)

Success is in his genes
Bob Chapman lights up shellfish genes for a living. The cutting-edge science might become the key to keeping Lowcountry estuaries healthy. The S.C. Department of Natural Resources marine scientist uses the new genetics field of human genomics, how genes mutate in response to stresses such ... (Sun, 11 Nov 2007 06:02:52 GMT)

Genetic Drift: The True Nature of Race
The study of human genes has sparked a resurgence of debate about the true nature of race, even when scientists are declaring that race was not a valid scientific concept (Sun, 11 Nov 2007 10:27:31 GMT)

Top Stories News
A team students from National Yang Ming University (NYMU) students have won a gold medal at the International Genetic Engineering Machine 2007 (iGEM 2007) competition. (Sun, 11 Nov 2007 15:10:48 GMT)

Science & Technology News
A team students from National Yang Ming University (NYMU) students have won a gold medal at the International Genetic Engineering Machine 2007 (iGEM 2007) competition. (Sun, 11 Nov 2007 15:10:59 GMT)

Professor looks at DNA to answer life's questions
Ripan Malhi is the kind of guy who you think might pop up as a character in the various permutations of a TV drama about crime scene investigation. The co-founder, chief executive officer and research director of Trace Genetics, a genetic ancestry company, has been a DNA expert witness in court cases nationally. (Sun, 11 Nov 2007 17:06:34 GMT)

ARS scientists re-examine soy diversity
An Agricultural Research Service (ARS)-led team of scientists has challenged the widely held assumption that two “genetic bottlenecks” have drastically reduced genetic variability in soybean varieties grown in farmers' fields. (Sun, 11 Nov 2007 18:17:20 GMT)

Panel on genetics of cancer planned
TROY - The role of genetics in diagnosing cancer early is going to be closely scrutinized and discussed Tuesday at "Cancer Genetics and Research: What Does it Have to Do with Me?," a panel discussion hosted by ToLife!, a regional nonprofit organization headquartered in Delmar that provides education and support to people stricken with cancer. (Mon, 12 Nov 2007 03:49:51 GMT)

Ken Heebner Buys Cisco Systems Inc., MetLife Inc., Halliburton Company, Sells McDonald's Corp., MasterCard Inc., ...
While a lot of value Gurus are struggling, Ken Heebner��s CGM Focus Fund gained 68% year to date. Thanks to his large exposure in energy and basic material stocks and small positions in financials. He typically has large turnovers. These are his buys and sells during the third quarter. (Mon, 12 Nov 2007 04:28:34 GMT)

Blood test a new tool for dementia patients
http://www.JewishWorldReview.c | Q: Over the past several years, my mother, now 83 years old, has becoming increasingly forgetful — leaving the oven on, locking herself outside her house, losing her car keys, getting lost near her house and so on. (Mon, 12 Nov 2007 06:28:38 GMT)

FarmOnline
Sheep and wool producers across Australia now have a Visual Sheep Scores pocket guide to consistently describe, record and class sheep for subjective visual traits - a new national language. (Mon, 12 Nov 2007 07:17:51 GMT)

Innovation center nurtures start-ups
Just like racing turtles, startup companies don't always make it to the finish, said Dave Dunlap, founder of the language-learning software provider Coccinella Development Inc. (Mon, 12 Nov 2007 07:27:10 GMT)

Ludesi Hires Application Specialists From Bio-RAD, GE Healthcare & Nonlinear Dynamics
Ludesi AB, developer and provider of the world's leading 2D Gel Image Analysis Service, today announced that it has hired three new application specialists, Krisztina Halasz, Anna Kapferer, and Helena Lexander, to work closely with its existing customers and to meet the growing global demand for its service. Prior to joining Ludesi, the three new application specialists held key positions at ... (Mon, 12 Nov 2007 08:00:00 GMT)

Ethanol clue under their feet
For years, a researcher scoured soil samples from around the world in search of the perfect microbe; turns out dirt found near the lab excels at turning plant fibers into ethanol. (Mon, 12 Nov 2007 08:09:09 GMT)

Decoding DNA fast, cheap
One day, patients may give a drop of blood at their doctor's office and get a complete reading of their DNA to determine things like whether they carry the Alzheimer's gene or are predisposed to cancer. And it'll cost less than $100 and take only eight hours. That's the goal of a West Philadelphia start-up called BioNanomatrix Inc. that believes it has the technology and expertise to sequence an ... (Mon, 12 Nov 2007 09:26:35 GMT)

Tree sitters remain perched at UCSC
About five tree sitters spent their third day nested in redwood trees above the UC Santa Cruz parking lot where a protest had turned violent earlier in the week but on Friday was teeming with students, art and food. (Mon, 12 Nov 2007 10:15:58 GMT)

Evaluating Cardioprotective Properties Of Insulin In First Large-Scale Trial
The ability of insulin to limit heart-tissue damage during a heart attack will be tested in a landmark clinical trial led by Paresh Dandona, M.D., Ph.D., University at Buffalo Distinguished Professor in the departments of Medicine and Pharmacology and Toxicology in the UB School of Medicine and Biomedical Sciences.Approximately 600 patients at 90 centers in the U.S. [click link for full article] (Mon, 12 Nov 2007 10:19:12 GMT)

Applied Biosystems and BioTrove, Inc. to Collaborate on Integrated Platform for High-Throughput Genotyping
FOSTER CITY, Calif. & WOBURN, Mass.----Applied Biosystems , an Applera Corporation business, today announced that it has signed a licensing and collaboration agreement with BioTrove, Inc. to commercialize an analysis platform for high-throughput genotyping applications. (Mon, 12 Nov 2007 12:00:00 GMT)

Xilinx Announces Commercial Availability of First Front Side Bus FPGA High Performance Computing Solution for Intel(R) ...
SC07 -- Xilinx, Inc. , the world's leading supplier of programmable solutions, today announced it has begun commercial licensing of the high-performance computing industry's first FPGA-based acceleration solution to interface with the Intel Front Side Bus . (Mon, 12 Nov 2007 12:30:00 GMT)

Samir Brahmachari is new director general of CSIR
New Delhi, Nov 12 (IANS) Eminent scientist Samir K. Brahmachari was Monday appointed the new director general of the Council of Scientific and Industrial Research (CSIR), the country's largest scientific body that has had no full-time chief for the past 10 months. (Mon, 12 Nov 2007 12:36:37 GMT)

Global Market For Biomarkers Slated For High Growth Through 2012
According to a new technical market research report, BIOMARKERS: THE EXPANDING GLOBAL MARKET (BIO61A) from BCC Research www.bccresearch.com, the global market for biomarkers is expected to be worth $5.6B in 2007. (Mon, 12 Nov 2007 12:37:28 GMT)

Samir Brahmachari is new director general of CSIR
New Delhi, Nov 12: Eminent scientist Samir K. Brahmachari was Monday appointed the new director general of the Council of Scientific and Industrial Research (CSIR), the country's largest scientific body that has had no full-time chief for the past 10 months. (Mon, 12 Nov 2007 12:48:23 GMT)

Samir Brahmachari is new director general of CSIR
New Delhi, Nov 12 - Eminent scientist Samir K. Brahmachari was Monday appointed the new director general of the Council of Scientific and Industrial Research (CSIR), the country's largest scientific body that has had no full-time chief for the past 10 months. (Mon, 12 Nov 2007 13:25:54 GMT)

Samir Brahmachari is new chief of CSIR
Eleven months after R A Mashelkar retired from the leadership of India's apex research body Council of Scientific and Industrial Research (CSIR), the government today appointed Samir K. Brahmachari, director, Institute of Genomics & Integrative Biology (IGIB), Delhi, as new CSIR chief. (Mon, 12 Nov 2007 14:16:49 GMT)

DRC Computer and Mitrionics Form Strategic Partnership to Deliver Affordable Acceleration for Compute-Intensive ...
Supercomputing 2007, SC07 Booth #272 -- DRC Computer Corporation, the leading provider of dynamically reconfigurable coprocessor modules, today announced a strategic partnership with Mitrionics(TM) AB, developer of the Mitrion(TM) Software Acceleration Platform and the Mitrion Virtual Processor. (Mon, 12 Nov 2007 15:00:00 GMT)

Xilinx Ships Front Side Bus FPGA High Performance Computing Solution
RENO , Nev. – ( NASDAQ:XLNX ) Xilinx, Inc. has said that it has begun commercial licensing of the high-performance computing industry's first FPGA-based acceleration solution to interface with the Intel Front Side Bus (FSB). Enabled by the high-performance 65nm Virtex-5 platform FPGA and Intel QuickAssist Technology, the Xilinx Accelerated Computing Platform (ACP) M1 licensing package supports ... (Mon, 12 Nov 2007 15:01:20 GMT)

From Lab Table to President's Chair
SHIRLEY TILGHMAN | educator (Mon, 12 Nov 2007 15:03:11 GMT)

Samir Brahmachari takes over as CSIR head
New Delhi, Nov 12: Dr Samir Brahmachari, a pioneer in functional genomics initiative in India, today took charge as the new Director General of the Council of Scientific and Industrial Research (CSIR), ending months of uncertainty over the post. (Mon, 12 Nov 2007 15:39:20 GMT)

UNC chair honored for tech research
The chairman of computer science at UNC Charlotte's College of Computing and Informatics has been honored for his research on virtual-reality technologies used to treat phobias. (Mon, 12 Nov 2007 16:52:39 GMT)

T-Bay biotech firm goes global
Nearly five years after its inception, Thunder Bay-based Genesis Genomics has formed a partnership with a worldwide leader in skin care to bring the company’s first product to market. (Mon, 12 Nov 2007 17:17:08 GMT)

Foster City, California and Woburn, Massachussets November 12, 2007
Applied Biosystems (NYSE: ABI), an Applera Corporation business, today announced that it has signed a licensing and collaboration agreement with BioTrove, Inc. (Mon, 12 Nov 2007 17:17:38 GMT)

JHU taking biotech studies to Web
Johns Hopkins University unveiled new online degree offerings Monday, including advanced study in biotechnology programs. (Mon, 12 Nov 2007 18:04:13 GMT)

AnaSpec Introduces Thirteen New Catalog Peptides
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirteen (13) new catalog peptides. Bak BH3 (71-89)- Cat# 62261 This peptide is amino acids 71 to 89 fragment of the Bak BH3 domain .The BH3 domain plays a critical role in mediating the cell death and protein-binding functions of Bak. It is a pro-apoptotic protein. Bak BH3 peptides trigger the rapid ... (Mon, 12 Nov 2007 18:17:23 GMT)

WallStreetSavant.com Announces Profile Coverage of Eugene Science, Inc.
Wall Street Savant, LLC (www.wallstreetsavant.com) today announced initiation of Profile Coverage on Eugene Science, Inc. on its website. Eugene Science, Inc. is a global Biotechnology company tackling ailments such as heart disease, obesity and diabetes through innovation in the Nutraceutical field. Its first commercial heart disease product, CZ™ is a patented, Nanoscience-based, ... (Mon, 12 Nov 2007 18:21:54 GMT)

Xilinx Announces Commercial Availability of First Front Side Bus FPGA High Performance Computing Solution for Intel(R) ...
RENO, Nev. ( Map ) - RENO, Nev., Nov. 12 /PRNewswire/ -- SC07 -- Xilinx, Inc. (Nasdaq: XLNX ), the world's leading supplier of programmable solutions, today announced it has begun commercial licensing of the high-performance computing industry's first FPGA-based acceleration solution to interface with the Intel Front Side Bus (FSB). Enabled by the high-performance 65nm Virtex(TM)-5 platform FPGA ... (Mon, 12 Nov 2007 18:42:31 GMT)

Open source drug discovery proponent is new CSIR chief
Eleven months after RA Mashelkar retired from the leadership of India’s apex research body, Council of Scientific and Industrial Research (CSIR), the government today appointed Samir K Brahmachari, director, Institute of Genomics & Integrative Biology (IGIB), New Delhi, as the new chief. (Mon, 12 Nov 2007 18:48:22 GMT)

Win Fabulous Prizes, All in the Name of Innovation
With millions of dollars as the draw, foundations unleash entrepreneurship in the public interest. (Mon, 12 Nov 2007 20:10:59 GMT)

Vermillion Reports Third Quarter 2007 Financial Results and Business Progress
Vermillion, Inc. today announced financial results for its third quarter ended September 30, 2007 and an update on business progress. (Mon, 12 Nov 2007 21:05:00 GMT)

Memory Pharmaceuticals Appoints Paul Blake to Board of Directors
Memory Pharmaceuticals Corp. today announced the appointment of Paul Blake to the Company's Board of Directors effective November 9, 2007. (Mon, 12 Nov 2007 21:10:00 GMT)

Memory Pharmaceuticals Appoints Paul Blake to Board of Directors
MONTVALE, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. ( Nachrichten ) today announced the appointment of Paul Blake to the Company's Board of Directors effective November 9, 2007. Dr. Blake has over 27 years of clinical development experience. (Mon, 12 Nov 2007 21:18:03 GMT)

French Family Science Center Opens
Durham, NC -- Duke alumna Melinda French Gates, left, front, talks with Duke Chemistry Assistant Professor Katherine Franz (in red jacket) during the tour of the new French Family Science Center Friday. (Mon, 12 Nov 2007 21:36:32 GMT)

Safeway to give nearly $17 million for breast cancer research
Safeway Inc. said Thursday it will provide nearly $17 million for breast cancer research and prevention programs in the United States and Canada, following a monthlong fundraising and public service campaign in all of its 1,738 stores. (SWY) (Mon, 12 Nov 2007 21:44:57 GMT)

Overexpression of Human Protein Reduces Severity of Alzheimer's Disease in Mice
Buck Institute study shows potential of human protein to lessen severity of Alzheimer's disease. (Mon, 12 Nov 2007 22:27:47 GMT)

Nanogen to Trim Business Unit, Work Force
Nanogen Inc., a San Diego-based maker of diagnostic products, said Nov. 12 that it would close its microarray business and cut its work force by 20 percent. (Mon, 12 Nov 2007 23:47:03 GMT)

S K Brahmachari is the new CSIR chief
Eleven months after RA Mashelkar retired from the leadership of India's apex research body, Council of Scientific and Industrial Research (CSIR), the government on Monday appointed Samir K Brahmachari, director, Institute of Genomics & Integrative Biology (IGIB), New Delhi, as the new chief. Brahmachari will also head the Department of Scientific and Industrial Research (DSIR) as secretary. (Tue, 13 Nov 2007 07:31:08 GMT)

Three New Studies Show Benefits Of NuVim's Key Ingredient
NuVim, Inc. announced recently that three studies were recently published relating to GTC Nutrition's flagship ingredient solution NutraFlora (short-chain fructooligosaccharides (scFOS) prebiotic fiber) (Tue, 13 Nov 2007 09:00:32 GMT)

AnaSpec Introduces Thirteen New Catalog Peptides AnaSpec Inc. Posted on: 09 Nov 07
Today AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced thirteen (13) new catalog peptides. (Tue, 13 Nov 2007 09:42:16 GMT)

Congress approves defense bill sending $180 million to Alaska
The U.S. Congress late last week approved a defense spending bill for fiscal year 2008 with more than $180 million in funds for Alaska projects. (Tue, 13 Nov 2007 10:34:29 GMT)

Cogenics Adopts NuGEN Ovation(R) Systems Target Preparation For Analysis Using Affymetrix GeneChip(R) Arrays
SAN CARLOS, Calif.----NuGEN Technologies, Inc., a privately held company that develops and commercializes nucleic acid amplification and labeling systems, announced today that the Cogenics division of Clinical Data, Inc., a global provider of genomics services, has adopted NuGEN's popular Ovation® Systems for RNA amplification and target preparation using Affymetrix GeneChip® 3' expression ... (Tue, 13 Nov 2007 11:00:00 GMT)

NIH selects LIAI for major study on allergy molecular causes and possible treatments
SAN DIEGO – (November 13, 2007) A major study that will provide a new window into understanding and potentially treating allergies will be conducted by the La Jolla Institute for Allergy & Immunology (LIAI) under a $5 million federal contract. (Tue, 13 Nov 2007 11:14:29 GMT)

Oregon Health and Science University (OHSU) Microarray Core Facility Licenses MetaCore From GeneGo
GeneGo, Inc., the leading provider of databases, software and services in systems biology, announced today that OHSU Affymetrix microarray core facility licensed a portfolio of its data analysis products. (Tue, 13 Nov 2007 12:00:00 GMT)

Cyntellect Appoints David Voris Chief Financial Officer
Cyntellect, Inc., a life sciences company pioneering the development and commercialization of laser-based live-cell manipulation systems, announced today that it has appointed David Voris as its Vice President of Finance & Administration and Chief Financial Officer. (Tue, 13 Nov 2007 13:00:00 GMT)

Genedata Joins Japanese Research Initiative For Metastatic Biomarkers
Swiss-based research informatics provider Genedata today announced its collaboration with Tokyo Medical University, AMR Inc., and Leica Microsystems in a proteomics research initiative aiming at the identification of metastatic biomarkers for the discovery and validation of new protein drug targets (Tue, 13 Nov 2007 13:22:33 GMT)

Cogenics Adopts NuGEN Ovation Systems Target Preparation For Analysis Using Affymetrix GeneChip Arrays
NuGEN Technologies, Inc., a privately held company that develops and commercializes nucleic acid amplification and labeling systems, announced today that the Cogenics division of Clinical Data, Inc., a global provider of genomics services, has adopted NuGEN's popular Ovation Systems for RNA amplification and target preparation using Affymetrix GeneChip 3' expression arrays (Tue, 13 Nov 2007 13:37:31 GMT)

Infrastructure Improvements Would Pay Off for Biopharma Firms, Study Says
Research Triangle Park — Biopharmaceutical firms looking to lower research and development costs could save hundreds of millions of dollars by upgrading their technology infrastructure, a study by RTI International reports. (Tue, 13 Nov 2007 17:10:56 GMT)

PROTEOME SCIENCES PLC: Statement re Issuance of US Patent
PROTEOME SCIENCES plc ( Nachrichten ) Issuance of US Patent for Isobaric Tandem Mass Tags® (TMT®) 13 November 2007. (Tue, 13 Nov 2007 17:50:54 GMT)

NIH Selects La Jolla Institute For Allergy & Immunology For Major Study On Allergy Molecular Causes And Possible ...
A major study that will provide a new window into understanding and potentially treating allergies will be conducted by the La Jolla Institute for Allergy & Immunology (LIAI) under a $5 million federal contract. [click link for full article] (Tue, 13 Nov 2007 20:18:51 GMT)

Vioxx Settlement Puts Painkillers Back in the Spotlight
Title: Vioxx Settlement Puts Painkillers Back in the Spotlight Category: Health News Created: 11/10/2007 2:00:00 AM Last Editorial Review: 11/12/2007 (Tue, 13 Nov 2007 20:31:30 GMT)

OHSU's Microarray Core Facility Licenses GeneGo's Software Suite
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 13 Nov 2007 20:58:06 GMT)

Japanese Proteomics Initiative to Use Genedata's Expressionist Software
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Tue, 13 Nov 2007 20:58:16 GMT)

Other highlights in the Nov. 13 JNCI
A new, simpler model for predicting estrogen receptor-positive breast cancer risk in postmenopausal women appears to perform almost as well as the standard model. (Tue, 13 Nov 2007 21:13:14 GMT)

Local News Genesis Genomics part of encoding DNA project
Thunder Bay's Genesis Genomics announced Monday that it is involved in a three-year international venture to produce a database and device that will read genetic makeup to identify all lifeforms. (Tue, 13 Nov 2007 21:16:16 GMT)

Accelrys to Offer Free Version of its Scientific Operating Platform to Academic Researchers
Accelrys, ( Nachrichten ) Inc. (NASDAQ:ACCL), a leading provider of scientific business intelligence solutions, announced the release of SciTegic Pipeline Pilot â„¢ Student Edition software, a free stand-alone version of its scientific operating platform. (Tue, 13 Nov 2007 21:17:56 GMT)

Researchers Identify Tumor-Suppressor Gene for Lung Cancer
The GPRC5A gene, which is under-expressed in human lung cancer cells, suppresses lung tumors in mouse models and could provide a key to attacking lung cancer in humans, researchers at The University of Texas M. D. Anderson Cancer Center report in the Nov. 21 edition of The Journal of the National Cancer Institute. (Tue, 13 Nov 2007 21:21:46 GMT)

BioDiscovery Joins Illumina Connect Bioinformatics Program
BioDiscovery announced today that it joined Illumina Connect, a bioinformatics program offered by Illumina, Inc., for downstream analysis of microarray data. After collaborating with Illumina, BioDiscovery has successfully created an interface that allows customers using both Illumina's BeadStudio software to seamlessly process their data in BioDiscovery's Nexus CGH advanced copy number ... (Tue, 13 Nov 2007 22:37:00 GMT)

Trial looks at ability of insulin to limit heart-tissue damage during a heart attack
The ability of insulin to limit heart-tissue damage during a heart attack will be tested in a landmark clinical trial led by Paresh Dandona, M.D., Ph.D., University at Buffalo Distinguished Professor in the departments of Medicine and Pharmacology and Toxicology in the UB School of Medicine and Biomedical Sciences. (Wed, 14 Nov 2007 00:00:25 GMT)

Overexpression of neuroglobin reduces severity of Alzheimer's disease in mice
Mice genetically engineered to both overproduce the protein neuroglobin and to develop Alzheimer's disease (AD) had a much milder form of the disease when compared to mice engineered to have AD alone, researchers at the Buck Institute for Age Research have reported. (Wed, 14 Nov 2007 00:16:07 GMT)

Micro Petri dish allows unprecedented miniaturisation of the growth of micro-organisms
Scientists of Top Institute Food & Nutrition, Wageningen University and Research Centre, NIZO food research and the MESA+ Institute for Nanotechnology in the Netherlands have developed a new technology that allows unprecedented miniaturisation of the growth of micro-organisms. (Wed, 14 Nov 2007 00:17:27 GMT)

Tumor-suppressor Gene For Lung Cancer Identified
The GPRC5A gene, which is under-expressed in human lung cancer cells, suppresses lung tumors in mouse models and could provide a key to attacking lung cancer in humans, researchers report. (Wed, 14 Nov 2007 02:07:52 GMT)

Dr Samir Brahmachari takes charge as CSIR head
Dr Samir K. Brahmachari, Director, Institute of Genomics & Integrative Biology (IGIB), Delhi, has taken charge as secretary, Department of Scientific and Industrial Research (DSIR) and Director General, Council of Scientific & Industrial Research (CSIR), from Dr T Ramasami, secretary, Department of Science & Technology (DST), who was holding the additional charge as Director General, CSIR and ... (Wed, 14 Nov 2007 02:32:25 GMT)

La Jolla Institute for Allergy & Immunology to perform study on allergy molecular causes
A major study that will provide a new window into understanding and potentially treating allergies will be conducted by the La Jolla Institute for Allergy & Immunology (LIAI) under a $5 million federal contract. (Wed, 14 Nov 2007 07:30:58 GMT)

UVa, Eastern Va. medical schools team up
The University of Virginia School of Medicine and Eastern Virginia Medical School announced Tuesday a partnership that is expected to boost federal research funding, expand clinical trials for experimental drugs and lead to medical research breakthroughs. "This is a nice opportunity for both institutions to take advantage of the strengths at the two places," said Dr. Ron Turner, UVa's senior ... (Wed, 14 Nov 2007 08:06:03 GMT)

Translational Medicine in Biopharmaceutical R&D: Enabling R&D Optimization and Early Detection of Potential Failures
LYON, France----Reportlinker.com announces that a new market research report related to the worldwide pharmaceutical industry is available in its catalogue. (Wed, 14 Nov 2007 09:01:00 GMT)

VGX Pharmaceuticals' SynCon™ Pandemic Flu Vaccine Protects Against A Lethal Challenge Of Live Virus In Pre-Clinical ...
VGX Pharmaceuticals' SynCon™ (Synthetic Consensus) pandemic flu DNA vaccines (VGX-3400) provided protection against a lethal challenge of live H5N1 viruses, according to data presented by Dr. Ruxandra Draghia-Akli at the MVAF 2007-Modern Vaccines/Adjuvants Formulation Conference in Dublin, Ireland. Dr. [click link for full article] (Wed, 14 Nov 2007 11:18:53 GMT)

Tumor-Suppressor Gene For Lung Cancer Identified By M. D. Anderson Researchers
The GPRC5A gene, which is under-expressed in human lung cancer cells, suppresses lung tumors in mouse models and could provide a key to attacking lung cancer in humans, researchers at The University of Texas M. D. Anderson Cancer Center report in the Nov. 21 edition of The Journal of the National Cancer Institute. [click link for full article] (Wed, 14 Nov 2007 11:19:03 GMT)

New Dundee Research Collaboration to Evaluate Drug Safety Risks Early
Evaluating the safety of drugs early in development to ensure the safety of patients is a major issue facing the pharmaceutical industry as shown by some recent high profile withdrawals of new drugs in the later stages of testing. (Wed, 14 Nov 2007 11:50:38 GMT)

Fluorotechnics Expands Global Capability via Acquisition of ETC Elektrophorese-Technik
SYDNEY, Australia & KIRCHENTELLINSFURT, Germany----Fluorotechnics today announced the acquisition of ETC Elektrophorese-Technik. Under the terms of the acquisition, Fluorotechnics will acquire all issued shares in ETC Elektrophorese-Technik in exchange for Fluorotechnics shares. (Wed, 14 Nov 2007 11:52:00 GMT)

Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline
Analysts, fund managers, and investors heard first-hand the progress and prospects of three of Cell Therapeutics, Inc.'s oncology drug candidates, as well as information on a drug CTI expects to acquire this year, from an international panel of clinical investigators at a Company-sponsored analyst day entitled "New Strategies, New Opportunities" in New York on Friday, November 9. (Wed, 14 Nov 2007 12:00:00 GMT)

Genedata Joins Japanese Research Initiative For Metastatic Biomarkers
Swiss-based research informatics provider Genedata announced its collaboration with Tokyo Medical University, AMR Inc., and Leica Microsystems in a proteomics research initiative aiming at the identification of metastatic biomarkers for the discovery and validation of new protein drug targets. [click link for full article] (Wed, 14 Nov 2007 12:18:02 GMT)

Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of NeoVisc(R) in Eastern Europe
Stellar Pharmaceuticals Inc.(OTC.BB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today reported signing a licensing agreement with Torrex Chiesi Pharma GmbH, based in Vienna, Austria in respect of the distribution and sale of NeoVisc®, a product used for the treatment of osteoarthritis, in Eastern Europe. (Wed, 14 Nov 2007 12:30:00 GMT)

Invitrogen and CytRx Subsidiary RXi Pharmaceuticals Collaborate to Enhance RNAi Technologies for Therapeutic ...
CARLSBAD, Calif. & WORCESTER, Mass.----Invitrogen Corporation , a provider of essential life science technologies for research, production and diagnostics, and CytRx Corporation's majority-owned subsidiary RXi Pharmaceuticals Corporation today announced that they have entered into an agreement whereby RXi will exclusively license second generation RNA interference technology from Invitrogen for ... (Wed, 14 Nov 2007 13:00:00 GMT)

Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in ...
Rosetta Genomics, Ltd. announced today the initiation of in vivo studies in its microRNA-based liver cancer therapeutic program conducted in collaboration with Isis Pharmaceuticals . (Wed, 14 Nov 2007 13:30:00 GMT)

Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in ...
REHOVOT, Israel and NORTH BRUNSWICK, New Jersey, November 14 /PRNewswire-FirstCall/ -- Rosetta Genomics, ( Nachrichten ) Ltd. (NASDQ: ROSG) announced today the initiation of in vivo ( Nachrichten ) studies in its microRNA-based liver cancer therapeutic program conducted in collaboration with Isis Pharmaceuticals(1) . The project, combining Isis's extensive know how and IP in antisense chemistry ... (Wed, 14 Nov 2007 13:50:31 GMT)

Gentelligent, Inc. Asks 'Is your DNA in Excel?'
Gentelligent, Inc. today announced the launch of BasePro 1.0, the world's first Excel-based software to handle DNA, RNA and protein data. A downloadable add-in, Base Pro provides over 40 functions for rapid and intuitive manipulation of biological sequences. (Wed, 14 Nov 2007 14:00:00 GMT)

Ancient retroviruses spurred evolution of gene regulatory networks in humans and other primates
SANTA CRUZ, CA--When ancient retroviruses slipped bits of their DNA into the primate genome millions of years ago, they successfully preserved their own genetic legacy. (Wed, 14 Nov 2007 16:15:00 GMT)

Nanogen Opts to Close Microarray Business, Axe 20 Percent of Staff
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription. (Wed, 14 Nov 2007 16:27:24 GMT)

Previous 1 2 3 4 Next